Evaluation of GD2 expression in patients with osteosarcoma

被引：0
|
作者：
Tarim, John [1 ]
Sowers, Rebecca S. [1 ]
Piperdi, Sajida [1 ]
Khanna, Chand [2 ]
Gorlick, Richard G. [1 ]
机构：
[1] Childrens Hosp Montefiore, Bronx, NY USA
[2] NCI, Bethesda, MD 20892 USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-5332
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5332
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Ganglioside GD2 expression is maintained upon recurrence in patients with osteosarcoma
    Poon, Vincent I.
    Roth, Michael
    Piperdi, Sajida
    Geller, David
    Gill, Jonathan
    Rudzinski, Erin R.
    Hawkins, Douglas S.
    Gorlick, Richard
    CLINICAL SARCOMA RESEARCH, 2015, 5
  • [2] GANGLIOSIDE GD2 EXPRESSION IS MAINTAINED UPON RECURRENCE IN PATIENTS WITH OSTEOSARCOMA
    Poon, V., I
    Roth, M.
    Piperdi, S.
    Geller, D.
    Gill, J.
    Ridzinski, E. R.
    Hawkins, D. S.
    Gorlick, R.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2015, 63 (01) : 201 - 201
  • [3] First-in-Humans PET/MRI of In Vivo GD2 Expression in Osteosarcoma
    Trautwein, Nils Florian
    Reischl, Gerald
    Seitz, Christian
    Dittmann, Helmut
    Seith, Ferdinand
    Scheuermann, Sophia
    Feuchtinger, Tobias
    Dombrowski, Frank
    Handgretinger, Rupert
    Fuchs, Joerg
    Pichler, Bernd
    la Fougere, Christian
    Schwenck, Johannes
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (02) : 337 - 338
  • [4] Surface expression of the immunotherapeutic target GD2 in osteosarcoma depends on cell confluency
    Wiebel, Malena
    Kailayangiri, Sareetha
    Altvater, Bianca
    Meltzer, Jutta
    Grobe, Kay
    Kupich, Sabine
    Rossig, Claudia
    CANCER REPORTS, 2021, 4 (05)
  • [5] Expression of Disialoganglioside GD2 in Neuroblastomas of Patients Treated with Immunotherapy
    Terzic, T.
    Teira, P.
    Cournoyer, S.
    Peuchmaur, M.
    Sartelet, H.
    LABORATORY INVESTIGATION, 2013, 93 : 449A - 449A
  • [6] Expression of Disialoganglioside GD2 in Neuroblastomas of Patients Treated with Immunotherapy
    Terzic, T.
    Teira, P.
    Cournoyer, S.
    Peuchmaur, M.
    Sartelet, H.
    MODERN PATHOLOGY, 2013, 26 : 449A - 449A
  • [7] GD2 expression in breast cancer
    Orsi, Giulia
    Barbolini, Monica
    Ficarra, Guido
    Tazzioli, Giovanni
    Manni, Paola
    Petrachi, Tiziana
    Mastrolia, Ilenia
    Orvieto, Enrico
    Spano, Carlotta
    Prapa, Malvina
    Kaleci, Shaniko
    D'Amico, Roberto
    Guarneri, Valentina
    Dieci, Maria Vittoria
    Cascinu, Stefano
    Conte, Pierfranco
    Piacentini, Federico
    Dominici, Massimo
    ONCOTARGET, 2017, 8 (19) : 31592 - 31600
  • [8] Ganglioside GD2 as a Therapeutic Target for Antibody-Mediated Therapy in Patients With Osteosarcoma
    Roth, Michael
    Linkowski, Marissa
    Tarim, John
    Piperdi, Sajida
    Sowers, Rebecca
    Geller, David
    Gill, Jonathan
    Gorlick, Richard
    CANCER, 2014, 120 (04) : 548 - 554
  • [9] Differential expression of the gangliosides GD3 and GD2 in canine and human osteosarcoma cell lines: An immunotherapy target
    Milner, Rowan J.
    Chimura, Noaki
    Bowles, Kristina D.
    Salute, Marc
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (10)
  • [10] The expression of gangliosides GD2 is associated with worse prognosis in melanoma patients
    Kong, Yan
    Yu, Jiayi
    Si, Lu
    Chi, Zhihong
    Cui, Chuanliang
    Sheng, Xinan
    Guo, Jun
    CANCER RESEARCH, 2016, 76
12345